Survodutide targets the GLP-1 receptor and glucagon receptor
"Triple-hormone-receptor agonist retatrutide for obesityA phase 2 trial." New England Journal of Medicine , 389(6), 514-526
This year, GLP-1 agonists, which have gained a lot of buzz in recent times for treating metabolic conditions, were added to WHO Essential Medicines List, in hopes that this could make them more accessible
A diagnosis made through a website isn't a diagnosis and you deserve better than that
The literature reports that carnitine can promote the excretion of excess organic or fatty acids in patients with defects in fatty acid metabolism and/or specific organic acidopathies that bioaccumulate acylCoA esters.1-6 Secondary carnitine deficiency can be a consequence of inborn errors of metabolism or iatrogenic factors such as hemodialysis
The gut microbiotabrain axis in behaviour and brain disorders